John Kemp

John has over 30 years of experience in neuroscience research and CNS drug discovery and development. Prior to joining Syndesi, John spent the last 6 years as Senior Director Neuroscience Discovery at Janssen leading research into novel treatments for Alzheimer’s disease. John was previously Chief Research and Development officer at Evotec, having served as CEO of the spin-out Evotec Neurosciences that raised €25M in funding. Before joining Evotec, John was head of CNS Research at Roche in Basel and a member of the Global Research Portfolio Committee and CNS Disease Area Strategic Team. He also held senior research positions in Neuroscience R&D at Merck Sharpe and Dohme in the UK. John has published over 140 peer reviewed articles, was an original member of ISI’s Most Highly Cited Researcher Database and has a particular interest and expertise in synaptic physiology.